JupiteX Get the app
Health & Medicine18 Nov 2026 · about 6 min

Alzheimer's disease protein atlas reveals hidden cell-type biology

The brief

A cell-type-specific protein atlas maps protein levels separately in different kinds of cells, rather than treating brain tissue as one mixture. It matters because Alzheimer’s affects almost the entire brain, yet its effects on individual cell types remain incompletely understood. St. Jude researchers built the atlas from two mouse models, combining mass spectrometry with single-cell RNA sequencing and spatial omics. They profiled more than 13,000 proteins and identified over 3,000 protein-level changes across cell types; 78% had not been captured before. This view also exposed differences between RNA and protein patterns and possible communication between cells. For example, astrocytes had high pleiotrophin RNA while microglia had high pleiotrophin protein. The resource gives researchers cell-specific clues about disease mechanisms and candidates for follow-up, not confirmed treatments. It also restores context that bulk profiling can lose.

01

What is a cell-type-specific protein atlas, and what does it show about Alzheimer's disease?

A cell-type-specific protein atlas maps protein levels separately in different kinds of cells, rather than treating brain tissue as one mixture. It matters because Alzheimer’s affects almost the entire brain, yet its effects on individual cell types remain incompletely understood.

St. Jude researchers built the atlas from two mouse models, combining mass spectrometry with single-cell RNA sequencing and spatial omics. They profiled more than 13,000 proteins and identified over 3,000 protein-level changes across cell types; 78% had not been captured before.

This view also exposed differences between RNA and protein patterns and possible communication between cells. For example, astrocytes had high pleiotrophin RNA while microglia had high pleiotrophin protein. The resource gives researchers cell-specific clues about disease mechanisms and candidates for follow-up, not confirmed treatments. It also restores context that bulk profiling can lose.

02

How many proteins did the researchers profile, and how many altered proteins had not been captured before?

The team profiled more than 13,000 proteins across multiple ages and cell types. The work used brains from two Alzheimer’s disease mouse models and combined next-generation mass spectrometry with single-cell RNA sequencing and spatial omics.

Across the cell types, the researchers found more than 3,000 proteins with altered levels. Of those altered proteins, 78% had not been captured before. The figure describes protein-level changes identified through the cell-type-specific approach, not the total number of proteins measured.

These findings show how much information can be missed when protein analysis lacks cell-type resolution. The atlas also let researchers compare protein patterns with RNA data and identify potential cellular interactions. The researchers said the data provide a resource for future single-cell analysis in Alzheimer’s disease samples and point to potential disease drivers for follow-up studies. They did not report treatments resulting from the findings.

03

Why can studying brain tissue in bulk hide changes happening in particular cell types?

Brain tissue contains many kinds of cells, and bulk analysis measures their combined material. That combined view can lose the context of which cell type has a particular protein change. This matters in Alzheimer’s disease, which can affect almost the entire brain while affecting different cell types in distinct ways.

The study compared cell-type-specific protein data with bulk data sets and found that many detected changes were new. Across the atlas, more than 3,000 proteins had altered levels, and 78% of those changes had not been captured before. Microglia provided a striking example: almost all the changes detected in this cell type were previously undetected.

The researchers addressed the problem by pairing deep proteomic profiling with single-cell RNA sequencing and spatial omics. This made it possible to examine protein changes in particular cell types and compare them with RNA patterns. The result is a more detailed view of disease biology, including possible signaling between cells, and a resource for researchers studying Alzheimer’s samples.

04

What did the atlas reveal about changes in microglia, a brain cell type linked to Alzheimer's risk genes?

The atlas revealed that almost all the changes detected in microglia were previously undetected. Microglia are especially relevant to the study because they express many genes associated with Alzheimer’s disease risk. The finding shows why it can matter to examine protein changes in individual cell types rather than relying only on bulk measurements.

The researchers profiled proteins by cell type and compared the results with other data, including single-cell RNA sequencing. This approach exposed changes that bulk protein data sets had not captured. The study also found potential intercellular signaling, though the microglia result itself highlights how much cell-specific protein biology had been missed.

The atlas does not establish that every newly detected microglia change causes Alzheimer’s disease. Instead, it gives researchers a more specific set of findings to investigate. The authors described potential disease drivers as candidates for future follow-up studies. The data also offer a resource for exploring how microglia and other cell types may interact in Alzheimer’s disease.

05

How can a protein made by astrocytes end up functioning in microglia?

A protein made by astrocytes can reach microglia if it is secreted from the astrocytes and then functions in the microglia. The study’s RNA-protein comparison suggested this kind of intercellular communication, in which a protein’s source and its site of action can differ.

Pleiotrophin was the example: researchers saw high RNA levels in astrocytes but high protein levels in microglia. Their proposed mechanism is that gene regulation occurs in astrocytes, where the RNA instructions are present; after translation, the protein is secreted and functions in microglia. The study presents this as a suggestion based on the differing patterns.

This finding adds a possible layer of communication to the cell-specific view of Alzheimer’s disease. It does not by itself prove the full route or establish pleiotrophin’s effects in disease. The atlas can help researchers investigate such interactions, including those between microglia and astrocytes, and identify which cell-specific signals merit follow-up.

06

How could identifying cell-specific protein changes help researchers study or target Alzheimer's disease?

Cell-specific protein changes can help researchers see which cells are affected and how their biology differs in Alzheimer’s disease. That matters because the disease can affect almost the entire brain, while bulk measurements can lose information about individual cell types. The atlas adds protein-level detail alongside RNA and spatial data.

For example, the researchers found high pleiotrophin RNA in astrocytes but high pleiotrophin protein in microglia. They suggested that the protein may be made and secreted by astrocytes, then function in microglia. This points to a possible interaction between cell types that can be investigated further, rather than a confirmed disease mechanism.

The team also identified potential disease drivers that could be targeted in future follow-up studies. The atlas and accompanying data sets are intended as a resource for further research, including single-cell analysis in Alzheimer’s disease samples. The findings do not show that any candidate is already a safe or effective treatment; they help prioritize questions and targets for study.

07

How do cells use genetic instructions in RNA to make proteins, and why might RNA and protein levels differ?

In basic cell biology, a gene’s DNA instructions are copied into RNA, and cellular machinery uses that RNA as a template to assemble a protein. This process is called translation. The article compares RNA and protein measurements but does not explain this general mechanism; this description comes from established biology.

RNA and protein levels can differ because making a protein is not a simple one-to-one readout of RNA abundance. Translation, protein breakdown, and secretion can affect how much protein is present in a cell. The study’s example was pleiotrophin: RNA levels were high in astrocytes, while protein levels were high in microglia. The researchers suggested that secretion could help explain this mismatch.

Comparing both kinds of measurement can therefore reveal biology that either alone might miss. Here, the mismatch suggested a possible path for communication between cell types. The finding remains a proposed interpretation, not proof of every step. The combined approach gives researchers a way to investigate such differences and cellular interactions in Alzheimer’s disease.

This brief was written by AI from the original reporting and checked by other models. Names, figures and quotes come from the source; read it for full context.

Read more in the JupiteX app

Pulse is free. New stories every 4 hours, each one broken into the questions that explain it.

Or read more news on the web